Group 1 - The core revenue for Fosun International reached 87.283 billion RMB, with a net profit attributable to shareholders of 661 million RMB and basic earnings per share of 0.08 RMB [1] - The overseas business revenue increased to 46.67 billion RMB, accounting for 53% of total revenue, which is a 6.6 percentage point increase compared to the same period in 2024 [1] - The company invested 3.6 billion RMB in technology innovation during the reporting period, particularly in the healthcare sector, contributing to the revaluation of underlying asset values [1] Group 2 - The total revenue from the top four subsidiaries, including Fosun Pharma, Yuyuan, Fosun Portugal Insurance, and Fosun Tourism, amounted to 63.61 billion RMB, representing 73% of the group's total revenue [2] - The operating profit for the group was 3.15 billion RMB, reflecting a year-on-year decline of 9.3%, primarily due to the decrease in profits from the leisure business segment [2] - The insurance business, led by Fosun Portugal Insurance, showed strong revenue growth, which partially offset the decline in profits from other segments [1][2]